Rothschild & CO Asset Management Us Inc. Amphastar Pharmaceuticals, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$17.21 - $20.65 $3.87 Million - $4.65 Million	-224,946 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$17.76 - $21.24 $336,782 - $402,774	-18,963 Reduced 7.77%	224,946 $4.52 Million
Q3 2020 Nov 09, 2020	SELL	$17.99 - $22.22 $745,433 - $920,707	-41,436 Reduced 14.52%	243,909 $4.57 Million
Q2 2020 Aug 10, 2020	BUY	$14.25 - $22.46 $14,492 - $22,841	1,017 Added 0.36%	285,345 $6.41 Million
Q1 2020 May 14, 2020	SELL	$12.66 - $20.08 $626,176 - $993,176	-49,461 Reduced 14.82%	284,328 $4.22 Million
Q4 2019 Feb 12, 2020	SELL	$17.07 - $20.64 $230,752 - $279,011	-13,518 Reduced 3.89%	333,789 $6.44 Million
Q3 2019 Nov 08, 2019	SELL	$19.12 - $22.62 $4,129 - $4,885	-216 Reduced 0.06%	347,307 $6.89 Million
Q2 2019 Jul 25, 2019	BUY	$18.92 - $22.96 $642,466 - $779,652	33,957 Added 10.83%	347,523 $7.34 Million
Q1 2019 May 08, 2019	SELL	$19.46 - $25.28 $435,203 - $565,361	-22,364 Reduced 6.66%	313,566 $6.41 Million
Q4 2018 Feb 05, 2019	BUY	$17.72 - $22.51 $243,774 - $309,670	13,757 Added 4.27%	335,930 $6.69 Million
Q3 2018 Nov 13, 2018	SELL	$15.39 - $19.38 $102,620 - $129,225	-6,668 Reduced 2.03%	322,173 $6.2 Million
Q2 2018 Aug 07, 2018	BUY	$14.63 - $19.6 $192,486 - $257,877	13,157 Added 4.17%	328,841 $5.02 Million
Q1 2018 May 08, 2018	SELL	$17.23 - $20.35 $183,551 - $216,788	-10,653 Reduced 3.26%	315,684 $5.92 Million
Q4 2017 Feb 12, 2018	SELL	$17.76 - $19.75 $492,236 - $547,391	-27,716 Reduced 7.83%	326,337 $6.28 Million
Q3 2017 Nov 08, 2017	BUY	$14.73 - $17.99 $5.22 Million - $6.37 Million	354,053	354,053 $6.33 Million

Others Institutions Holding AMPH

# of Institutions

279

Shares Held

34.2M

Call Options Held

25.5K

Put Options Held

24.8K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.35B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account